NEO — NEOGENOMICS INC

Ownership history in EntryPoint Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in NEOGENOMICS INC (NEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.13% (2025 Q2)
Avg. % of fund
0.1%
First filed
2024 Q2
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 23,176 -12,314 -34.7% 0.07% $179K $7.72
2025 Q2 ADDED 35,490 +31,062 +701.5% 0.13% $259K $7.31
2024 Q2 INITIATED 4,428 — — 0.09% $61K —
% of Fund (quarterly)    NEO price (monthly, adj. close)

Other funds also holding NEO

As of 2025 Q4 — sorted by position size

First Light Asset Management, LLC 3Y 7Y 9.02% Greenhouse Funds LLLP 3Y 7Y 3.67% HighMark Wealth Management LLC 3Y 2.72% PFM Health Sciences, LP 3Y 7Y 1.99% BRAIDWELL LP 3Y 1.74% Bullseye Asset Management LLC 3Y 1.5% Samjo Management, LLC 1.39% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 1.32% AMERICAN CAPITAL MANAGEMENT INC 3Y 7Y 1.21% WHITE PINE CAPITAL LLC 3Y 7Y 0.5%
← Back to EntryPoint Capital, LLC Holdings